A Model of Care Based on Electronic Patient-Reported Outcomes for the Early Detection and Management of Immune-Related Adverse Events in Patients Under Immunotherapy: A Multicentric Phase II Randomized Controlled Trial (IePRO).

Prof. Dr. rer. Med. Manuela Eicher and Prof. Dr. med. Olivier Michielin have been awarded this “allocated fund for nursing research”, derived from a private donation, starting in November 2018.

News & Events

Posted on

A study led by Professors Hanahan, Zeng, Saghafinia and Chryplewicz has uncovered a protein overexpressed in numerous cancer types that suppresses the…

Read more
Posted on

We were very honored to welcome Federal Councilor Guy Parmelin to our annual conference on the challenges in cancer research.

This event was a great…

Read more
Posted on

Congratulations to Prof. Elisa Oricchio – ISREC Foundation Chair in Translational Oncology from 2014 to 2020 – appointed Director of the ISREC…

Read more
Posted on

In recognition of her exceptional commitment to scientific research, Prof. Susan M. Gasser, director of the ISREC Foundation, received an honorary…

Read more